Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
31%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
27%
ALSO IN THNR
THNR
19
HOLDINGS
58%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 12.3% | 10.1% |
 |
ASTRAZENECA PLC | 4.7% | 5.3% | 4.7% |
|
MERCK & CO. INC. | 4.2% | 6.0% | 4.2% |
|
ABBVIE INC | 3.0% | 5.0% | 3.0% |
|
AMGEN INC | 2.1% | 7.8% | 2.1% |
HRTS Overweight Relative to THNR
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.9% |
|
JOHNSON & JOHNSON | 4.8% |
|
UNITEDHEALTH GROUP INC | 4.0% |
|
THERMO FISHER SCIENTIFIC INC | 3.8% |
|
GILEAD SCIENCES INC | 3.8% |
|
NOVARTIS AG | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
ABBOTT LABORATORIES | 3.4% |
|
DANAHER CORP | 2.8% |
|
BRIDGEBIO PHARMA, INC. | 2.8% |
HRTS Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -9.6% |
 |
SHIONOGI & CO LTD | -6.2% |
|
AMGEN INC | -5.7% |
|
CHUGAI PHARMACEUTICAL CO LTD | -5.4% |
|
PFIZER INC | -5.3% |
|
ROCHE HOLDING LTD | -5.1% |
 |
INNOVENT BIOLOGICS, INC. | -4.7% |
|
REGENERON PHARMACEUTICALS | -4.7% |
 |
CHINA PHARMACEUTICAL GROUP | -4.0% |
|
HIMS & HERS HEALTH, INC. CLASS A | -2.5% |